Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking. METHODS: We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the Global Cardiovascular Risk Consortium. We examined associations between the risk factors (body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes) and incident cardiovascular disease and death from any cause using Cox regression analyses, stratified according to geographic region, age, and sex. Population-attributable fractions were estimated for the 10-year incidence of cardiovascular disease and 10-year all-cause mortality. RESULTS: Among 1,518,028 participants (54.1% of whom were women) with a median age of 54.4 years, regional variations in the prevalence of the five modifiable risk factors were noted. Incident cardiovascular disease occurred in 80,596 participants during a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants died during a median follow-up of 8.7 years (maximum, 47.6). For all five risk factors combined, the aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% confidence interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men, and the corresponding values for 10-year all-cause mortality were 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6). CONCLUSIONS: Harmonized individual-level data from a global cohort showed that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. (Funded by the German Center for Cardiovascular Research (DZHK); ClinicalTrials.gov number, NCT05466825.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As well as the significant improvement in diabetic control, cardiometabolic risk was also improved by a significant reduction in SBP which was recorded across the cohort, specifically for those who had one or more co-existing medical conditions and for those who had a diagnosis of T2D of less than 6 years29.”
From mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
(2010) · University of Twente Research Information · Cited by 6,037
Auditory and non-auditory effects of noise on health
Basner, M., Babisch, W., Davis, A., Brink, M., Clark, C., Janssen, S., & Stansfeld, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61613-x · Cited by 2,473 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330 · cited 3×
“While tobacco consumption is strongly associated with premature mortality, elevated blood pressure and cholesterol are more specifically related to CVD. 7 A tailored reduction in the burden of CVD and all-cause mortality for persons and populations can be achieved with better understanding of the region-and sex-specif…”
InfluentialEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Yusuf, S., Joseph, P., Rangarajan, S., Islam, S., Mente, A., Hystad, P., Brauer, M., Kutty, V. R., Gupta, R., Wielgosz, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32008-2 · Cited by 2,017
SCORE2 working group and ESC Cardiovascular risk collaboration, Hageman, S., Pennells, L., Ojeda, F., Kaptoge, S., Kuulasmaa, K., de Vries, T., Xu, Z., Kee, F., Chung, R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab309 · Cited by 1,810
Wood, A. M., Kaptoge, S., Butterworth, A. S., Willeit, P., Warnakula, S., Bolton, T., Paige, E., Paul, D. S., Sweeting, M., Burgess, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30134-x · Cited by 1,188 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors
Joseph, P., Leong, D., McKee, M., Anand, S. S., Schwalm, J.-D., Teo, K., Mente, A., & Yusuf, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.308903 · Cited by 1,073
Time-to-Event Analysis of Longitudinal Follow-up of a Survey: Choice of the Time-scale
Korn, E. L., Graubard, B. I., & Midthune, D. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009034 · Cited by 1,007
Lifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cardiovascular Disease and Risk Factors in Asia: A Selected Review
Ueshima, H., Sekikawa, A., Miura, K., Turin, T. C., Takashima, N., Kita, Y., Watanabe, M., Kadota, A., Okuda, N., Kadowaki, T., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.790048 · Cited by 919 · cited 1×
“18,19 Among them, high blood pressure is associated with up to 13.5% of all deaths annually worldwide, and is considered as the leading risk factor for CVD. 20 Strict blood pressure control to a systolic blood pressure of less than 120 mmHg has been associated with lower rates of cardiovascular…”
InfluentialPredicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study
Pencina, M. J., D'Agostino, R. B., Larson, M. G., Massaro, J. M., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.816694 · Cited by 870
Air Pollution and Noncommunicable Diseases
Schraufnagel, D. E., Balmes, J. R., Cowl, C. T., De Matteis, S., Jung, S.-H., Mortimer, K., Perez-Padilla, R., Rice, M. B., Riojas-Rodriguez, H., Sood, A., et al. (2019) · Chest · doi:10.1016/j.chest.2018.10.041 · Cited by 851
Bryazka, D., Reitsma, M. B., Griswold, M. G., Abate, K. H., Abbafati, C., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abdoli, A., Abdollahi, M., Abdullah, A. Y. M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00847-9 · Cited by 582
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
Neumann, J. T., Twerenbold, R., Ojeda, F., Sörensen, N. A., Chapman, A. R., Shah, A. S. V., Anand, A., Boeddinghaus, J., Nestelberger, T., Badertscher, P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803377 · Cited by 346
Walli-Attaei, M., Joseph, P., Rosengren, A., Chow, C. K., Rangarajan, S., Lear, S. A., AlHabib, K. F., Davletov, K., Dans, A., Lanas, F., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30543-2 · Cited by 330 · cited 1×
“The Global Cardiovascular Risk Consortium and other studies 14–16 confirmed apparent differences in cardiovascular risk factor profile and event rates in women compared to men, irrespective of geographic region.”
Brunner, F. J., Waldeyer, C., Ojeda, F., Salomaa, V., Kee, F., Sans, S., Thorand, B., Giampaoli, S., Brambilla, P., Tunstall-Pedoe, H., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32519-x · Cited by 305 · cited 1×
“While there is a strong continuous association between non-HDL cholesterol and incident CVD, 22 we and others 3,23,24 observed a U-shaped association of non-HDL cholesterol with all-cause mortality.”
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
Blankenberg, S., Salomaa, V., Makarova, N., Ojeda, F., Wild, P., Lackner, K. J., Jørgensen, T., Thorand, B., Peters, A., Nauck, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw172 · Cited by 273 · cited 1×
“Biomarkers 32,33 and genetic variants most likely would add to CVD risk prediction.”
Yadlowsky, S., Hayward, R. A., Sussman, J. B., McClelland, R. L., Min, Y.-I., & Basu, S. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3011 · Cited by 271
Johannesen, C. D. L., Langsted, A., Mortensen, M. B., & Nordestgaard, B. G. (2020) · BMJ · doi:10.1136/bmj.m4266 · Cited by 251
Walli-Attaei, M., Rosengren, A., Rangarajan, S., Breet, Y., Abdul-Razak, S., Sharief, W., AlHabib, K. F., Avezum, Á., Chifamba, J., Díaz, R., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01441-6 · Cited by 160 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Joseph, P. G., Kutty, V. R., Mohan, V., Kumar, R., Mony, P. K., Vijayakumar, K., Islam, S., Iqbal, R., Kazmi, K. A., Rahman, O., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac249 · Cited by 134
MORGAM (an international pooling of cardiovascular cohorts)
Evans, A. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh327 · Cited by 128
Jaspers, N. E. M., Blaha, M. J., Matsushita, K., van der Schouw, Y. T., Wareham, N. J., Khaw, K.-T., Geisel, M. H., Lehmann, N., Erbel, R., Jöckel, K.-H., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz239 · Cited by 120
Liu, Y., Liu, F., Zhang, L., Li, J., Kang, W., Mingli, C., Song, F., & Song, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-01738-w · Cited by 47 · cited 1×
“While there is a strong continuous association between non-HDL cholesterol and incident CVD, 22 we and others 3,23,24 observed a U-shaped association of non-HDL cholesterol with all-cause mortality.”
SASMacros for Calculation of Population Attributable Fraction in a Cohort Study Design
Laaksonen, M. A., Virtala, E. T., Knekt, P., Oja, H., & Härkänen, T. (2011) · Journal of Statistical Software · doi:10.18637/jss.v043.i07 · Cited by 41
Evolocumab’s Long-Term Mortality Risk Unclear Due to Shortened Follow-Up of FOURIER
van Bruggen, F. H., & Luijendijk, H. J. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00480-y · Cited by 7
Cited by
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P., Townsend, N., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 314
Liu, J., Li, Y., Ge, J., Yan, X., Zhang, H., Zheng, X., Lu, J., Li, X., Gao, Y., Lei, L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01028-6 · Cited by 258
Cui, C., Liu, L., Qi, Y., Han, N., Xu, H., Wang, Z., Shang, X., Han, T., Zha, Y., Wei, X., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02244-9 · Cited by 186
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
The Global Cardiovascular Risk Consortium (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2415879 · Cited by 187
Self-citationLinz, D., Andrade, J. G., Arbelo, E., Boriani, G., BREITHARDT, G. E., Camm, A. J., Caso, V., Nielsen, J. C., Melis, M. D., Potter, T. J. R. D., et al. (2024) · EP Europace · doi:10.1093/europace/euae070 · Cited by 128
Metadata
- Authors
- The Global Cardiovascular Risk Consortium
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- The Global Cardiovascular Risk Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-05
- Volume
- 389
- Issue
- 14
- Pages
- 1273-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC10589462
- OpenAlex
- W4386194106
- Cited by
- 909
- References
- 35
- Citations by year
- 2026: 285 · 2025: 359 · 2024: 242 · 2023: 23
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Union AFFECT-EU (Horizon 2020, No. 847770)
- German Center for Cardiovascular Research (not applicable)
- European Union MORGAM (Biomed, BMH4-CT98-3183)
- European Union GenomEUtwin (FP5, QLG2-CT-2002-01254)
- European Union ENGAGE (FP7, HEALTH-F4-2007-201413)
- European Union CHANCES (FP7, HEALTH-F3-2010-242244)
- European Union BiomarCaRE (FP7, HEALTH-F2-2011-278913)
- European Union euCanSHare (Horizon 2020, No. 825903)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- modifiable risk factors, cardiovascular disease, all-cause mortality, population attributable fraction, body mass index, systolic blood pressure, non-HDL cholesterol, smoking, diabetes mellitus, sex differences, regional variation, global cardiovascular risk, cohort studies, cardiovascular disease incidence, women's health
- MeSH terms
- Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk Factors, Smoking, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.